D. Russler-Germain
MD-PhD. Hematology/oncology physician-scientist-in-training. Tweet/RT not medical advice or endorsement.
Last synced from Twitter 10m ago
The Cancer Miracle Isn’t a Cure. It’s Prevention.
We cannot treat our way out of the rising trend in cancer cases. The only solution is a full-scale defense, so that nobody suffers the disease in the first place.
Achieving symptom relief in patients with Myalgic encephalomyelitis by targeting the neuro-immune interface and inducing disease tolerance
Myalgic encephalomyelitis, ME, previously also known as chronic fatigue syndrome (CFS) is a heterogeneous, debilitating syndrome of unknown etiology responsible for long-lasting disability in millions of patients worldwide. The most well-known...
Measuring actual learning versus feeling of learning in response to being actively engaged in the classroom
Despite active learning being recognized as a superior method of instruction in the classroom, a major recent survey found that most college STEM instructors still choose traditional teaching methods. This article addresses the long-standing...
Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma
Secondary CNS involvement (SCNS) is a profoundly adverse complication of diffuse large B-cell lymphoma. Evidence from older series indicated a median …
Tracing tumorigenesis in a solid tumor model at single-cell resolution
Understanding tumour development at a granular level is a challenge in solid tumours. Here, the authors provide a cell atlas across tumour development in a genetic model of salivary gland squamous cell carcinoma using single-cell transcriptome and...
Ta-Nehisi Coates on why political power isn’t enough for the right
Ta-Nehisi Coates and Vox’s Ezra Klein discuss cultural power, demographic change, and Ezra’s "cold, atheist book."
Hepatorenal syndrome
Hepatorenal syndrome (HRS) is defined as severe kidney functional impairment that occurs in patients with liver cirrhosis. This Primer discusses new diagnostic criteria of acute kidney injury in the context of HRS and also covers pathophysiology and...
I *WANT* an Angry Woman as My President, Actually
So don’t tell me Warren’s “anger” is a problem.
Behavioral Heuristics in Coronary-Artery Bypass Graft Surgery | NEJM
Correspondence from The New England Journal of Medicine — Behavioral Heuristics in Coronary-Artery Bypass Graft Surgery
How Common Mental Shortcuts Can Cause Major Physician Errors
Tendencies like left-digit bias can have life-altering consequences for patients.
Prognostic Awareness in Adult Oncology and Palliative Care
Communicating prognosis clearly and empathically can foster accurate prognostic awareness in patients with advanced cancer and their family members. Whereas patients and doctors desire clear prognostic communication, it presents many challenges in...
The case for Elizabeth Warren
The second article in a Vox series making the best case for the leading Democratic candidates.
Optimizing outcomes in relapsed/refractory Hodgkin lymphoma: a review of current and forthcoming therapeutic strategies - Theodoros P. Vassilakopoulos, John V. Asimakopoulos, Kostas Konstantopoulos, Maria K. Angelopoulou, 2020
The outcome of patients with relapsed/refractory classical Hodgkin lymphoma (rr-cHL) has improved considerably in recent years owing to the approval of highly a...
A doctor’s prescription to save patients money, grief and sticker shock
How entrepreneurs are disrupting health care’s ‘money games.’
Validation of the NCCN-IPI and the GELTAMO-IPI for diffuse large B-Cell lymphoma treated with R-CHOP in a large cohort of patients from a single institution
(2020). Validation of the NCCN-IPI and the GELTAMO-IPI for diffuse large B-Cell lymphoma treated with R-CHOP in a large cohort of patients from a single institution. Leukemia & Lymphoma: Vol. 61, No. 3, pp. 575-581.
Chemogenetic Control of Nanobodies
Engineered nanobody allows reversible control of activity in cells through the binding of small molecules.